Caribou Biosciences Announces the FDA Granted Regenerative Medicine Advanced Therapy (RMAT) Designation to CB-011, an Allogeneic Anti-BCMA CAR-T Cell TherapyGlobeNewsWire • 03/31/26
Caribou Biosciences: Antlers Up For The Allogenic CAR-T Bet Trading At Cash ValueSeeking Alpha • 03/17/26
Caribou Biosciences, Inc. (CRBU) Reports Q4 Loss, Tops Revenue EstimatesZacks Investment Research • 03/05/26
Caribou Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business UpdateGlobeNewsWire • 03/05/26
Watchmaker Genomics Licenses CRISPR-Cas9 Intellectual Property from Caribou Biosciences to Increase Throughput and Reduce Sequencing Cost per SampleBusiness Wire • 02/17/26
Caribou Biosciences Announces Late-Breaking Presentations at the 2026 Tandem Meetings of ASTCT® and CIBMTR®GlobeNewsWire • 02/04/26
Caribou Biosciences, Inc. (CRBU) Reports Q3 Loss, Misses Revenue EstimatesZacks Investment Research • 11/12/25
Caribou Biosciences Reports Third Quarter 2025 Financial Results and Provides Business UpdateGlobeNewsWire • 11/12/25
Caribou Biosciences Announces Positive Data from CaMMouflage Phase 1 Trial of CB-011 in Multiple MyelomaGlobeNewsWire • 11/03/25
Caribou Biosciences Announces Positive Data from ANTLER Phase 1 Trial Demonstrating Efficacy and Durability of Vispa-cel (CB-010), an Allogeneic CAR-T Cell Therapy, on Par with Autologous CAR-T Cell TherapiesGlobeNewsWire • 11/03/25
Caribou Biosciences to Host Webcast to Report New Data Updates from Two Allogeneic CAR-T Cell Therapy Programs in Lymphoma and Multiple MyelomaGlobeNewsWire • 11/02/25
Caribou Biosciences to Participate in the Citi 2025 Biopharma Back to School ConferenceGlobeNewsWire • 08/25/25
Caribou Biosciences Reports Second Quarter 2025 Financial Results and Provides Business UpdateGlobeNewsWire • 08/12/25
CARIBOU ALERT: Bragar Eagel & Squire, P.C. is Investigating Caribou Biosciences, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmGlobeNewsWire • 07/25/25
Caribou Biosciences to Participate in the Jefferies Global Healthcare ConferenceGlobeNewsWire • 05/28/25
Caribou Biosciences (CRBU) Upgraded to Buy: Here's What You Should KnowZacks Investment Research • 05/13/25
Caribou Biosciences Reports First Quarter 2025 Financial Results and Provides Business UpdateGlobeNewsWire • 05/08/25
Caribou Biosciences to Participate in the BofA Securities 2025 Health Care ConferenceGlobeNewsWire • 05/06/25
Will Caribou Biosciences, Inc. (CRBU) Report Negative Q1 Earnings? What You Should KnowZacks Investment Research • 04/29/25